Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2Phase NA 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

CNS 6Sarcoma 1Gastrointestinal 1Breast 1

Conditions

Brain Neoplasms 6Neoplasms 3Melanoma 3Glioma 3Stomach Neoplasms 2Glioblastoma 2Breast Neoplasms 2Thyroid Diseases 1Skin Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Neuroma, Acoustic 1Lung Neoplasms 1Laryngeal Neoplasms 1Irritable Bowel Syndrome 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Gastroesophageal Reflux 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Barrett Esophagus 1Astrocytoma 1Adenomatous Polyps 1Adenolymphoma 1

Interventions

Temozolomide 163Radiosurgery 128Radiotherapy 106Bevacizumab 97Magnetic Resonance Spectroscopy 74Carboplatin 48Surgical Procedures, Operative 35Etoposide 34pembrolizumab 33Radiation 33Nivolumab 33Irinotecan 33Cyclophosphamide 33Erlotinib Hydrochloride 31Carmustine 28Trastuzumab 25Lomustine 25Cisplatin 25Ipilimumab 24Filgrastim 23Mental Status and Dementia Tests 21Magnetic Resonance Imaging 21Aminolevulinic Acid 21Vincristine 20Surveys and Questionnaires 19Capecitabine 19Topotecan 18Specimen Handling 18Pemetrexed 18Radiotherapy, Intensity-Modulated 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Brain Neoplasms × Fluorescein × Clear all
NCT03823144 2025-12-11

Intravital Microscopy in Human Solid Tumors

Mayo Clinic

Phase NA Recruiting
85 enrolled
BreastCNSGastrointestinalSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02691923 2025-08-03

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
30 enrolled
CNS

Brain Neoplasms, Glioma

NCT04597801 2022-11-10

INVIVO

Technical University of Munich

Phase 2 Completed
210 enrolled
CNS

Brain Neoplasms

NCT02389530 2018-08-03

Use of Fluorescein Dye for the Removal of Brain Tumors

University of Pittsburgh

Completed
91 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms

NCT02478346 2017-02-14

Fluoescein

AdventHealth

Phase 4 Unknown
200 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

NCT02028325 2016-11-08

Fluorescein

Indiana University

Phase 4 Terminated
136 enrolled 4 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡